Kent Council Discusses Proposal for Medical Marijuana Dispensary

Aug.16.2022

The Kent planning committee is discussing a proposal for a medical marijuana dispensary on 331 E. Main St.

The Kent Planning Committee will discuss a proposal to establish a medical marijuana dispensary in the city once again.

The committee will convene at 7 pm on Tuesday evening to discuss a proposed pharmacy at 331 E. Main St in Kent County. The meeting will be held in the basement of the Kent Fire Department located at 320 S. DePeyster St.

The current company, Slightly Toasted, submitted a request for site planning and conditional zoning to the city's planning commission in January.

However, after considering input from neighbors and determining that additional details were needed in the on-site plan before voting, the expert panel did not vote.

The owner of Slightly Toasted has stated that if the pharmacy receives approval from the city government and obtains a permit from the state of Ohio, the e-cigarette store will relocate.

However, neighbors of the proposed medical marijuana dispensary are expressing concerns about its proximity to residential areas, the entrance of Kent State University, fraternity houses, and the municipal court.

Statement:

This article is compiled from third-party information sources and is intended solely for industry exchange and learning purposes.

This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity and accuracy of the content. The translation of this article is only intended for industry-related communication and research purposes.

Due to limitations in the level of translation, the translated article may not fully express the same meaning as the original. Please refer to the original article for accuracy.

2FIRSTS maintains complete alignment with the Chinese government regarding any domestic, Hong Kong, Macao, Taiwan, or foreign-related statements and positions.

The ownership of the copyright for the compiled information belongs to the original media and authors. If there is any infringement, please contact us for deletion.

#Asia #Market #China #Disposable e-cigarettes #Medical marijuana dispensary

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

PMI Q3 2025 Earnings: Net Revenues Reach $10.85 Billion, Smoke-Free Products Account for 41% of Sales

PMI reported strong third-quarter 2025 results, underscoring the continued success of its smoke-free transformation. Net revenues rose 9.4% year-over-year to $10.85 billion, driven by robust growth in the smoke-free segment, which now accounts for 41% of total net revenues and over 42% of gross profit.Despite a 3.2% decline in cigarette shipments, combustible revenues climbed 4.3% thanks to strong pricing.

Oct.21

EUIPO Rejects Imiracle’s Opposition to ‘Crystal’ Trademark, Citing Lack of Proof of Actual Use in Slovakia

The EUIPO has ruled that Imiracle failed to demonstrate actual commercial use of its “Elfbar Crystal” brand in Slovakia, and therefore rejected in full the company’s opposition to Shenzhen SKE Technology’s application to register the “Crystal” trademark. The EUIPO noted that the sales records submitted by Imiracle were limited in scope and that the product packaging was in Ukrainian, which it found insufficient to prove that the products had been placed on the Slovak market.

Dec.10 by 2FIRSTS.ai

ceshi1111

Trusted by industry leaders and innovators, ARAC brings unmatched expertise in Modules 5 & 6, including label and claim development, comprehension testing, human factors/usability, and clinical-behavioral research such as actual use and switching studies. These studies generate the robust, real-world evidence needed to evaluate whether products are “Appropriate for the Protection of Public Health” (APPH) -- including randomized experimental longitudinal, actual use, cohort st

Oct.21

Report: Smoking Rates Remain Unchanged Despite Kazakhstan’s Vape Ban

According to Exclusive.KZ, Kazakhstan’s Strategy Public Foundation released a study finding that strict tobacco and vape bans have not reduced smoking rates, which remain at 18–20%. The report calls for harm reduction approaches based on international best practices.

Nov.06 by 2FIRSTS.ai